neostigmine + sugammadex

Neostigmine + sugammadex is a combination of two pharmacological agents used for the reversal of neuromuscular blockade, particularly after the use of non-depolarizing neuromuscular blocking agents such as rocuronium. Neostigmine is an acetylcholinesterase inhibitor that increases acetylcholine levels at the neuromuscular junction, thereby antagonizing the effects of non-depolarizing muscle relaxants. Sugammadex is a selective relaxant binding agent that encapsulates and inactivates steroidal neuromuscular blocking drugs like rocuronium, leading to rapid reversal of their effects. The combination has been studied as a cost-effective alternative to full-dose sugammadex for deep blockade reversal and may be used sequentially when initial neostigmine reversal is incomplete[1][4]. This approach aims to balance efficacy with reduced drug costs while maintaining patient safety.

Brand names

BridionBloxiverzProstigmin

Other names

Combination of sugammadex and neostigmineSugammadex-neostigmine combinationHalf-dose sugammadex with neostigmine